mani
virus
capabl
induc
cell
death
lead
lysi
infect
cell
late
stage
viru
infect
morpholog
chang
commonli
known
cytopath
effect
cpe
microscop
observ
virusinduc
cpe
character
cell
round
shinkag
deform
nuclei
chomatin
condens
howev
earli
death
infect
cell
may
limit
viru
replic
also
apoptosi
program
cell
death
pcd
late
phase
viral
infect
suggest
play
import
role
viru
life
cycl
facilit
viral
progeni
releas
propag
pcd
process
damag
age
otherwis
unwant
cell
elimin
though
seri
step
result
destruct
genom
form
pcd
known
apoptosi
character
seri
morpholog
chang
includ
nuclear
condens
fragment
cytoplasm
bleb
cell
shinkag
mani
virus
capabl
induc
reactiv
oxygen
speci
ro
product
result
mani
studi
suggest
ro
directli
involv
induct
apoptosi
virusinfect
cell
hand
demonstr
viru
infect
increas
product
superoxid
anion
radic
neutrophil
macrophag
infiltr
lung
mice
transgen
mice
carri
overexpress
extracellular
superoxid
dismutas
exhibit
less
sever
lung
injuri
influenza
viru
infect
studi
therefor
postul
pathogenesi
viru
infect
involv
viru
prolifer
mediat
apoptot
cell
death
infect
cell
also
direct
rosinduc
cellular
injuri
neutrophil
macrophag
infiltr
virusinfect
organ
despit
mani
studi
event
lead
gener
ro
viral
infect
still
unclear
paper
demonstr
effect
quercetin
product
cpe
ro
dna
fragment
induct
pedv
infect
also
studi
relationship
antivir
antioxid
activ
antioxid
ribavirin
sulforhodamin
b
srb
purchas
sigmaaldrich
st
loui
mo
usa
chemic
reagent
grade
isol
aerial
part
houttuynia
cordata
use
previous
describ
method
vero
african
green
monkey
kidney
cell
line
atcc
kindli
provid
atcc
american
type
cultur
collect
manassa
va
usa
pedv
cv
porcin
epidem
diarrhea
viru
obtain
nation
veterinari
research
quarantin
servic
korea
vero
cell
maintain
minim
essenti
medium
mem
supplement
fetal
bovin
serum
fb
antibioticantimycot
antibioticantimycot
trypsinedta
fb
mem
suppli
gibco
brl
grand
island
ny
tissu
cultur
plate
purchas
falcon
bd
bioscienc
nj
usa
viru
stock
store
use
antivir
activ
cytotox
virus
determin
cytopath
effect
cpe
reduct
method
recent
report
also
effect
pedvinduc
cpe
observ
cytopath
effect
cpe
reduct
method
recent
report
ribavirin
use
posit
solubl
dimethylsulfoxid
dmso
use
neg
control
level
intracellular
ro
measur
alter
fluoresc
result
oxid
diacet
dcfhda
molecular
probe
eugen
dcfhda
dissolv
dmso
final
concentr
mm
use
measur
ro
cell
treat
reagent
time
period
indic
figur
legend
wash
twice
cold
pb
incub
dcfhda
min
dcfhda
stabl
compound
easili
diffus
cell
hydrolyz
intracellular
esteras
yield
reduc
nonfluoresc
compound
dcfh
trap
within
cell
ro
produc
cell
oxid
dcfh
highli
fluoresc
dcf
intens
fluoresc
record
use
flow
cytometri
becton
dickenson
excit
filter
nm
emiss
filter
nm
ro
level
calcul
ratio
ro
mean
intens
expos
cell
mean
intens
unexpos
cell
vero
cell
seed
onto
cultur
plate
concentr
cell
per
well
next
day
medium
remov
cell
wash
pb
ml
dilut
viru
suspens
ml
medium
supplement
typsinedta
contain
appropri
concentr
antivir
compound
ad
tenfold
dilut
scheme
compound
cultur
plate
incub
day
cell
lyse
lysi
buffer
te
buffer
mm
trishcl
ph
mm
nacl
mm
edta
sd
incub
min
ice
centrifug
rpm
min
cysol
dna
extract
phenol
chlororform
extract
supernat
dna
treat
mgml
rnase
min
dna
separ
agaros
gel
electrophoresi
dna
fragment
visual
digit
imag
gel
describ
day
infect
vero
cell
pedv
mock
cell
figur
cell
treat
figur
ribavirin
figur
show
typic
spreadout
shape
normal
morpholog
concentr
sign
cytotox
observ
infect
pedv
absenc
result
sever
cpe
figur
addit
infect
vero
cell
inhibit
format
visibl
cpe
figur
howev
addit
ribavirin
pedvinfect
vero
cell
imposs
prevent
cpe
figur
thu
cpe
viru
infect
prevent
presenc
investig
possibl
mechan
observ
antivir
effect
first
examin
whether
antioxid
properti
contribut
action
determin
influenc
pedv
replic
intracellular
ro
level
vero
cell
infect
pedv
variou
period
time
fluoresc
probe
dcfhda
ad
medium
prior
min
use
flow
cytometri
shown
figur
exposur
pedv
result
increas
ro
product
began
h
postinfect
peak
h
figur
studi
influenc
antioxid
ro
increas
pedv
infect
nac
use
shown
figur
h
postinfect
pedv
infect
result
drastic
increas
intracellular
ro
strongli
decreas
nac
accord
increas
concentr
studi
influenc
antioxid
pedv
replic
antioxid
nac
trolox
pdtc
use
shown
figur
four
compound
exhibit
cytotox
differ
concentr
antivir
activ
nac
pdtc
hardli
present
howev
trolox
strongli
exhibit
antivir
activ
concentr
decreas
rapidli
accord
dose
depend
manner
compar
effect
extent
dna
fragment
result
pedv
infect
examin
incub
ribavirin
concentr
h
induc
dna
fragment
mockinfect
vero
cell
figur
lane
pedv
infect
induc
dna
fragment
vero
cell
h
infect
absenc
compound
figur
lane
presenc
dna
fragment
induc
dosedepend
manner
figur
lane
dna
fragment
somewhat
decreas
vero
cell
infect
pedv
treat
ribavirin
concentr
h
incub
ribavirin
induc
dna
fragment
mani
virus
capabl
induc
cell
death
lead
lysi
infect
cell
late
stage
pedv
infect
morpholog
chang
commonli
known
cpe
microscop
observ
morpholog
vero
cell
infect
pedv
greatli
decreas
pedv
addit
howev
addit
ribavirin
pedvinfect
vero
cell
prove
imposs
prevent
cpe
viral
infect
rhinoviru
influenza
viru
human
immunodefici
viru
bovin
viral
diarreha
viru
frequent
result
gener
oxid
stress
infect
cell
event
lead
gener
ro
viral
infect
still
unclear
also
antioxid
shown
antivir
activ
varieti
unrel
virus
allevi
oxid
stress
gener
virus
mechanist
believ
virus
induc
apoptosi
oxid
stress
mediat
via
ro
interfer
pathway
antioxid
believ
inhibit
virusinduc
apoptosi
thu
inhibit
effici
viru
multipl
contrast
also
report
indic
certain
condit
compound
act
proapoptot
drug
depend
viral
system
analyz
antioxid
compound
differ
abil
reduc
viru
growth
flavonoid
larg
class
polyphenol
compound
jung
et
al
report
relationship
flavonoid
structur
antioxid
activ
found
inhibitori
activ
flavonoid
total
ro
strongli
increas
rise
number
hydroxyl
group
foavonoid
glycosid
structur
previou
studi
show
quercetin
nt
directli
interact
pedv
particl
affect
initi
stage
pedv
infect
interf
viral
mrna
product
report
present
evid
commonli
use
antioxid
abl
protect
cell
pedv
induc
death
potent
agent
shown
involv
number
process
suggest
antivir
effect
might
due
antioxid
function
alon
nevertheless
studi
need
verifi
underli
mechan
action
inhibit
pedv
infect
conclus
extrem
potent
antipedv
substanc
reduc
pedv
growth
inhibit
cpe
dna
fragment
infect
cell
regardless
antioxid
activ
nt
directli
interact
pedv
particl
affect
initi
stage
pedv
infect
obstruct
viral
mrna
product
interest
investig
antivir
activ
prevent
variou
pedvmedi
injuri
vivo
patholog
situat
author
declar
compet
interest
perform
exam
wholli
conceiv
studi
particip
design
draft
manuscript
author
read
approv
final
manuscript
